GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Glow Lifetech GLOW.CN · CAD

N/A · Canadian Securities Exchange · 🇨🇦 Canada

Compare

0.04

—

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Glow Lifetech

Its shares trade on Canadian Securities Exchange under the ticker GLOW.CN. It has been listed since 15 March 2021. In the fiscal year to 31 December 2025, it reported revenue of C$2.1m and a net loss of C$617,861. At that date it held total assets of C$3.9m and shareholders' equity of C$2.7m.

Glow LifeTech Corp. is a biotechnology company, which focuses on producing nutraceutical and cannabinoid-based products with bioavailability, absorption and effectiveness. The company is headquartered in Etobicoke, Ontario. The company went IPO on 2021-03-15. The firm has a partnership with a Health Canada licensed producer (MEDZ) for cannabis product manufacturing. The company performs manufacturing services within a dedicated facility under the quality and compliance control of MEDZ. The firm operates its own equipment as a contractor of MEDZ and all products are released under MEDZ license. The firm has continued the build out and testing of this manufacturing facility.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
15 Mar 2021

Leadership

Pay as last reported

  • Mr. Rob CarducciChief Executive Officer, Director, since 2024
  • Mr. Josh BaldChief Financial Officer, Corporate Secretary, since 2025
  • Mr. James van StaverenDirector, since 2024
  • Mr. David CoteIndependent Director
  • Mr. James FairbairnIndependent Director
  • Mr. Kelly MalcolmIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Glow Lifetech Corp's partnership with Health Canada licensed MEDZ ensures compliant cannabis manufacturing.
  • The dedicated facility under MEDZ quality control guarantees product safety and efficacy.
  • Bioavailability-focused nutraceuticals meet growing market demand for effective health solutions.

Weaknesses

  • Manufacturing services are limited to MEDZ's licensed facility without independent production capabilities.
  • Dependence on MEDZ for product release under their license restricts operational autonomy.
  • No mention of direct consumer market presence or retail distribution channels.

Opportunities

  • Expanding nutraceutical product lines could leverage Health Canada's regulatory framework.
  • Growing demand for cannabinoid-based health products in Canada presents market potential.
  • Testing and build-out of the manufacturing facility may lead to future expansion opportunities.

Threats

  • Health Canada regulatory changes could impact MEDZ's licensing and manufacturing operations.
  • Competition from other cannabis manufacturers may affect market share and pricing.
  • Economic downturns could reduce consumer spending on discretionary health products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.